Latest news and press releases about Disc Medicine, Inc. (IRON): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases.
Price
| Price | $68.57 |
| Market Cap | $2.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.78 |
| EV / EBITDA | -13.05 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -28.68% |
| Return on Invested Capital | -30.62% |
| Return on Assets | -26.30% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: AAPG · ADPT · APGE · CELC · CGON · LEGN · SRRK
Explore sector: Healthcare · Biotechnology
More sections of IRON: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks